Senolytic cocktail Dasatinib+Quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer [Online resource]
heading
Kovacovicova, K.; Školnaja, M.; Heinmaa, M.; Mistrik, M.; Pata, P.; Pata, I. et al.
author
statement of authorship
Kristina Kovacovicova, Marianna Skolnaja, Mihkel Heinmaa, Martin Mistrik, Pille Pata, Illar Pata, Jiri Bartek and Manlio Vinciguerra
source
journal volume number month
vol. 8
year of publication
pages
art. 459, 7 p. : ill
subject term
keyword
NAFLD (non-alcoholic fatty liver disease)
HCC (hepatocellular carcinoma)
senolytic agents
quercertin
dasatinib
ISSN
2234-943X
availibility
Võrguteavik
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
category (general)
kvartiil
TTÜ department
TTÜ department code
lk
country
ch
language
inglise
report field
aasta2018l
editor's notes
Ji 280119
Uurimisrühma
Kovacovicova, K.; Školnaja, M.; Heinmaa, M.; Mistrik, M.; Pata, P.; Pata, I. et al. Senolytic cocktail Dasatinib+Quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer [Online resource] // Frontiers in oncology (2018) vol. 8, art. 459, 7 p. : ill.